Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2385940
Max Phase: Preclinical
Molecular Formula: C23H19F3N2O4
Molecular Weight: 444.41
Molecule Type: Small molecule
Associated Items:
ID: ALA2385940
Max Phase: Preclinical
Molecular Formula: C23H19F3N2O4
Molecular Weight: 444.41
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C1c2cccc3cccc(c23)C(=O)N1CCNCCOc1ccc(OC(F)(F)F)cc1
Standard InChI: InChI=1S/C23H19F3N2O4/c24-23(25,26)32-17-9-7-16(8-10-17)31-14-12-27-11-13-28-21(29)18-5-1-3-15-4-2-6-19(20(15)18)22(28)30/h1-10,27H,11-14H2
Standard InChI Key: OBUPEUBWWZSJEX-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 444.41 | Molecular Weight (Monoisotopic): 444.1297 | AlogP: 4.00 | #Rotatable Bonds: 8 |
Polar Surface Area: 67.87 | Molecular Species: BASE | HBA: 5 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 8.83 | CX LogP: 4.62 | CX LogD: 3.18 |
Aromatic Rings: 3 | Heavy Atoms: 32 | QED Weighted: 0.42 | Np Likeness Score: -0.94 |
1. Guo P, Chen Q, Liu T, Xu L, Yang Q, Qian X.. (2013) Development of Unsymmetrical Dyads As Potent Noncarbohydrate-Based Inhibitors against Human β-N-Acetyl-d-hexosaminidase., 4 (6): [PMID:24900704] [10.1021/ml300475m] |
Source(1):